S&P 500 Futures
(-0.08%) 5 304.25 points
Dow J Futures
(-0.09%) 40 140 points
Nasdaq Futures
(-0.05%) 18 465 points
Oil
(-0.07%) $83.11
Gas
(-0.62%) $1.752
Gold
(0.73%) $2 254.80
Silver
(0.74%) $25.10
Platinum
(0.21%) $923.00
USD/EUR
(0.17%) $0.928
USD/NOK
(0.34%) $10.88
USD/GBP
(0.00%) $0.792
USD/RUB
(-0.23%) $92.36

Realtime updates for JCR Pharmaceuticals Co., [4552.T]

Exchange: JPX Sector: Healthcare Industry: Drug Manufacturers—General
Last Updated29 Mar 2024 @ 02:15

0.35% ¥ 859.00

Live Chart Being Loaded With Signals

Commentary (29 Mar 2024 @ 02:15):

Warning: Trying to access array offset on null in /home/getagraph/public_html/stock.php on line 302

JCR Pharmaceuticals Co., Ltd., a specialty pharmaceuticals company, engages in the research, development, manufacture, import and export, and sale of pharmaceutical products, regenerative medicines, and drug substances in Japan...

Stats
Today's Volume 570 800
Average Volume 703 026
Market Cap 107.20B
EPS ¥0 ( 2024-01-25 )
Next earnings date ( ¥16.69 ) 2024-05-08
Last Dividend ¥10.00 ( 2023-03-30 )
Next Dividend ¥0 ( N/A )
P/E 20.10
ATR14 ¥0.625 (0.07%)

Volume Correlation

Long: -0.06 (neutral)
Short: 0.21 (neutral)
Signal:(64.893) Neutral

JCR Pharmaceuticals Co., Correlation

10 Most Positive Correlations
10 Most Negative Correlations

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

JCR Pharmaceuticals Co., Correlation - Currency/Commodity

The country flag -0.73
( moderate negative )
The country flag -0.07
( neutral )
The country flag -0.54
( weak negative )
The country flag -0.67
( moderate negative )
The country flag -0.50
( neutral )
The country flag 0.62
( weak )

JCR Pharmaceuticals Co., Financials

Annual 2022
Revenue: ¥34.34B
Gross Profit: ¥25.46B (74.13 %)
EPS: ¥30.35
Q3 2023
Revenue: ¥9.45B
Gross Profit: ¥6.90B (73.09 %)
EPS: ¥-0.740
Q2 2023
Revenue: ¥13.46B
Gross Profit: ¥10.95B (81.30 %)
EPS: ¥29.19
Q1 2023
Revenue: ¥10.81B
Gross Profit: ¥7.45B (68.88 %)
EPS: ¥12.91

Financial Reports:

No articles found.

JCR Pharmaceuticals Co., Dividends

(Q3/22) (Q4/22) (Q1/23) (Q2/23) (Q3/23) (Q4/23) (Q1/24) (Q2/24) (Q3/24) (Q4/24)
¥10.00
(N/A)
¥0
(N/A)
¥10.00
(N/A)
¥0
(N/A)
¥0
(N/A)
¥0
(N/A)
¥0
(N/A)
¥0
(N/A)
¥0
(N/A)
¥0
(N/A)

JCR Pharmaceuticals Co., Dividend Information - Ex Dividend Knight

Dividend Sustainability Score: 10.00 - good (100.00%) | Divividend Growth Potential Score: 3.95 - Decrease likely (20.98%)

Very Unsafe

High risk of being cut

Unsafe

Heightened risk of being cut

Borderline

Moderate risk of being cut

Safe

Unlikely to be cut

Very Safe

Very unlikely to be cut

Information
First Dividend ¥1.250 2007-09-25
Last Dividend ¥10.00 2023-03-30
Next Dividend ¥0 N/A
Payout Date 0000-00-00
Next Payout Date N/A
# dividends 30 --
Total Paid Out ¥100.88 --
Avg. Dividend % Per Year 0.00% --
Score 3.49 --
Div. Sustainability Score 10.00
Div.Growth Potential Score 3.95
Div. Directional Score 7.30 --
Next Divdend (Est)
(2024-09-30)
¥0 Estimate 3.59 %
Dividend Stability
0.29 Very Poor
Dividend Score
3.49
Pay Frequency
Semi-Annually
Yearly Payout
Year Amount Yield

Warning: Undefined variable $stockPricesArray in /home/getagraph/public_html/stock.php on line 1111

Dividend Commentary

The company's strong Dividend Sustainability Score (DSS) indicates its robust capacity to uphold current dividend levels. Unfortunately, its low Dividend Growth Potential Score (DGPS) suggests limited prospects for dividend growth. In summary, the company provides a promising overall dividend outlook, balancing both sustainability and growth potential.

Top 10 dividend Companies for JPX

Symbol Title Last dividend Frequency Years Dividend Yearly Dividend Score
3591.T Ex Dividend Junior 2023-09-28 Semi-Annually 0 0.00%
2813.T Ex Dividend Knight 2024-03-28 Annually 0 0.00%
1515.T Ex Dividend Knight 2023-09-28 Semi-Annually 0 0.00%
9919.T Ex Dividend Knight 2023-09-28 Semi-Annually 0 0.00%
8960.T Ex Dividend Knight 2023-11-29 Semi-Annually 0 0.00%
8097.T Ex Dividend Knight 2023-09-28 Semi-Annually 0 0.00%
7458.T Ex Dividend Knight 2023-09-28 Semi-Annually 0 0.00%
6728.T Ex Dividend Junior 2024-06-27 Annually 0 0.00%
6099.T Ex Dividend Junior 2023-12-28 Annually 0 0.00%
4829.T Ex Dividend Junior 2024-05-30 Annually 0 0.00%

Dividend Sustainability Score (DSS)

RatioActual ValueWeightNormalized ValueScoreRange
netProfitMarginTTM0.1301.5007.4110.00[0 - 0.5]
returnOnAssetsTTM0.05221.2008.269.91[0 - 0.3]
returnOnEquityTTM0.09871.500-0.0142-0.0213[0.1 - 1]
payoutRatioTTM0-1.00000[0 - 1]
currentRatioTTM1.8010.8006.004.80[1 - 3]
quickRatioTTM1.0840.8008.336.67[0.8 - 2.5]
cashRatioTTM0.5731.5007.9310.00[0.2 - 2]
debtRatioTTM0.227-1.5006.22-9.33[0 - 0.6]
interestCoverageTTM105.821.00010.0010.00[3 - 30]
operatingCashFlowPerShareTTM45.132.0010.0010.00[0 - 30]
freeCashFlowPerShareTTM45.132.0010.0010.00[0 - 20]
debtEquityRatioTTM0.419-1.5008.33-10.00[0 - 2.5]
grossProfitMarginTTM0.7481.0000.8610.861[0.2 - 0.8]
operatingProfitMarginTTM0.1891.0008.218.21[0.1 - 0.6]
cashFlowToDebtRatioTTM0.2421.0009.779.77[0.2 - 2]
assetTurnoverTTM0.4020.800-0.650-0.520[0.5 - 2]
Total Score10.65

Dividend Growth Score (DGS)

RatioActual ValueWeightNormalized ValueScoreRange
peRatioTTM19.771.0008.100[1 - 100]
returnOnEquityTTM0.09872.50-0.00912-0.0213[0.1 - 1.5]
freeCashFlowPerShareTTM45.132.0010.0010.00[0 - 30]
dividendYielPercentageTTM3.531.50010.000[0 - 0.4]
operatingCashFlowPerShareTTM45.132.0010.0010.00[0 - 30]
payoutRatioTTM01.50000[0 - 1]
pegRatioTTM-0.2671.500-5.110[0.5 - 2]
operatingCashFlowSalesRatioTTM0.1361.0009.100[0.1 - 0.5]
Total Score3.95

JCR Pharmaceuticals Co.,

JCR Pharmaceuticals Co., Ltd., a specialty pharmaceuticals company, engages in the research, development, manufacture, import and export, and sale of pharmaceutical products, regenerative medicines, and drug substances in Japan. It offers various therapeutic products, including GROWJECT used for the treatment of growth hormone deficiency and short stature; IZCARGO to treat Mucopolysaccharidosis type II; Agalsidase Beta BS I.V. Infusion used for the treatment of Fabry disease; and TEMCELL HS Inj used to treat acute graft-versus-host disease. The company also develops Epoetin Alfa BS and Darbepoetin Alfa BS Injections for the treatment of renal anemia. In addition, it sells medical devices and laboratory instruments. JCR Pharmaceuticals Co., Ltd. was incorporated in 1975 and is headquartered in Ashiya, Japan.

About Live Signals

The live signals presented on this page help determine when to BUY or SELL NA. The signals have upwards of a 1-minute delay; like all market signals, there is a chance for error or mistakes.

The live trading signals are not definite, and getagraph.com hold no responsibility for any action taken upon these signals, as described in the Terms of Use. The signals are based on a wide range of technical analysis indicators